1/13
04:06 am
zvra
Zevra Therapeutics (NASDAQ:ZVRA) had its "sell (d+)" rating reaffirmed by analysts at
Weiss Ratings .
Medium
Report
Zevra Therapeutics (NASDAQ:ZVRA) had its "sell (d+)" rating reaffirmed by analysts at
Weiss Ratings .
1/8
07:30 am
zvra
Zevra Therapeutics to Present at the J.P. Morgan 44th Annual Healthcare Conference
Low
Report
Zevra Therapeutics to Present at the J.P. Morgan 44th Annual Healthcare Conference
1/3
07:27 am
zvra
Zevra Therapeutics: Asymmetric Risk-Reward Setup In Ultra-Rare Disease Market [Seeking Alpha]
Medium
Report
Zevra Therapeutics: Asymmetric Risk-Reward Setup In Ultra-Rare Disease Market [Seeking Alpha]
12/30
09:08 am
zvra
Zevra Therapeutics (NASDAQ:ZVRA) was given a new $26.00 price target on by analysts at HC Wainwright.
Low
Report
Zevra Therapeutics (NASDAQ:ZVRA) was given a new $26.00 price target on by analysts at HC Wainwright.
12/29
07:30 am
zvra
Zevra Therapeutics Executes Distribution Agreement to Broaden Access to MIPLYFFA® for the Treatment of Niemann-Pick Disease Type C (NPC)
Low
Report
Zevra Therapeutics Executes Distribution Agreement to Broaden Access to MIPLYFFA® for the Treatment of Niemann-Pick Disease Type C (NPC)
12/14
05:24 am
zvra
Is Zevra Therapeutics Attractively Priced After Recent Rare Disease Pipeline Progress? [Yahoo! Finance]
Low
Report
Is Zevra Therapeutics Attractively Priced After Recent Rare Disease Pipeline Progress? [Yahoo! Finance]
12/14
03:09 am
zvra
Is Zevra Therapeutics (ZVRA) Undervalued After Its Recent Share Price Pullback? [Yahoo! Finance]
Low
Report
Is Zevra Therapeutics (ZVRA) Undervalued After Its Recent Share Price Pullback? [Yahoo! Finance]
12/12
04:30 pm
zvra
Zevra Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Zevra Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
11/5/2025
04:05 pm
zvra
zevra therapeutics, inc.
BEAT
Report
-9.7%
zevra therapeutics, inc.
8/12/2025
04:05 pm
zvra
zevra therapeutics, inc.
MISS
Report
-19.8%
zevra therapeutics, inc.
5/13/2025
04:05 pm
zvra
zevra therapeutics, inc.
BEAT
Report
3.4%
zevra therapeutics, inc.
3/11/2025
04:05 pm
zvra
zevra therapeutics, inc.
MISS
Report
-1.9%
zevra therapeutics, inc.
1/7
04:18 pm
zvra
Form 4 ZEVRA THERAPEUTICS, INC. For: Dec 31 Filed by: Clifton R. LaDuane
Low
Report
Form 4 ZEVRA THERAPEUTICS, INC. For: Dec 31 Filed by: Clifton R. LaDuane
12/17
04:16 pm
zvra
Form 8-K ZEVRA THERAPEUTICS, INC. For: Dec 11
Low
Report
Form 8-K ZEVRA THERAPEUTICS, INC. For: Dec 11
12/9
04:18 pm
zvra
Form 4 ZEVRA THERAPEUTICS, INC. For: Dec 02 Filed by: Secor Alicia
Low
Report
Form 4 ZEVRA THERAPEUTICS, INC. For: Dec 02 Filed by: Secor Alicia
12/9
04:17 pm
zvra
Form 3 ZEVRA THERAPEUTICS, INC. For: Dec 02 Filed by: Secor Alicia
Low
Report
Form 3 ZEVRA THERAPEUTICS, INC. For: Dec 02 Filed by: Secor Alicia
12/2
07:34 am
zvra
Form 8-K ZEVRA THERAPEUTICS, INC. For: Nov 26
Low
Report
Form 8-K ZEVRA THERAPEUTICS, INC. For: Nov 26
11/20
04:29 pm
zvra
Form 8-K ZEVRA THERAPEUTICS, INC. For: Nov 20
Medium
Report
Form 8-K ZEVRA THERAPEUTICS, INC. For: Nov 20
11/14
04:19 pm
zvra
Form SCHEDULE 13G/A ZEVRA THERAPEUTICS, INC. Filed by: Woodline Partners LP
Medium
Report
Form SCHEDULE 13G/A ZEVRA THERAPEUTICS, INC. Filed by: Woodline Partners LP
11/13
09:02 am
zvra
Form SCHEDULE 13G/A ZEVRA THERAPEUTICS, INC. Filed by: Adage Capital Management, L.P.
Low
Report
Form SCHEDULE 13G/A ZEVRA THERAPEUTICS, INC. Filed by: Adage Capital Management, L.P.
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register